Prices are updated after-hours


Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date

symbols : Lly    crawled date : 2021 - 08 - 18    save search

Global Hot Tobacco Markets Report 2021-2025 & 2030: HNB Devices, Direct/Indirect Heating, Infused/Hybrid Devices, Consumables, Sticks, Capsules & Cartridges
Published: 2021-08-18 (Crawled : 20:00) - prnewswire.com
LLY | News | $726.31 -2.63% -0.04% 3.5M twitter stocktwits trandingview |
Health Technology
| | O: -0.88% H: 2.14% C: 1.6%
MO 4 | $42.09 1.91% -0.42% 22M twitter stocktwits trandingview |
Consumer Non-Durables
| | O: -0.83% H: 1.02% C: 0.88%

device
US FDA approves Jardiance® (empagliflozin) to treat adults living with heart failure with reduced ejection fraction
Published: 2021-08-18 (Crawled : 18:00) - prnewswire.com
LLY | News | $726.31 -2.63% -0.04% 3.5M twitter stocktwits trandingview |
Health Technology
| | O: -0.26% H: 1.01% C: -1.28%

fda heart fda approval
EQRx Appoints Richard Buckley as Chief Corporate Affairs Officer
Published: 2021-08-18 (Crawled : 12:00) - biospace.com/
LLY | News | $726.31 -2.63% -0.04% 3.5M twitter stocktwits trandingview |
Health Technology
| | O: -0.26% H: 1.01% C: -1.28%


Home-Use Insulin Delivery Devices Market to Hit $19,087.6 Million Revenue by 2030 says P&S Intelligence
Published: 2021-08-18 (Crawled : 08:00) - prnewswire.com
NVO | News | $122.71 -0.03% 0.17% 5M twitter stocktwits trandingview |
Health Technology
| | O: 0.04% H: 0.72% C: -0.91%
MDT | $79.48 0.37% -0.29% 6.7M twitter stocktwits trandingview |
Health Technology
| | O: 0.03% H: 0.28% C: -1.12%
LLY | News | $726.31 -2.63% -0.04% 3.5M twitter stocktwits trandingview |
Health Technology
| | O: -0.26% H: 1.01% C: -1.28%
BDX | $234.12 0.42% 0.0% 1.3M twitter stocktwits trandingview |
Health Technology
| | O: 0.07% H: 0.3% C: -2.11%
SNY | News | $46.32 2.05% 2.01% 3.3M twitter stocktwits trandingview |
Health Technology
| | O: 0.17% H: 1.16% C: -0.04%
PODD | $166.255 0.93% 0.92% 840K twitter stocktwits trandingview |
Health Technology
| | O: 0.21% H: 0.12% C: -2.14%

insulin device liver
Significant Weight Loss and Multiple Metabolic Benefits: Phase 1b Study Results of IBI362 in Chinese Participants with Overweight or Obesity Published in EClinicalMedicine by the Lancet
Published: 2021-08-18 (Crawled : 00:00) - prnewswire.com
LLY | News | $726.31 -2.63% -0.04% 3.5M twitter stocktwits trandingview |
Health Technology
| | O: -0.26% H: 1.01% C: -1.28%
INCY | $52.3 -0.98% -0.99% 2.2M twitter stocktwits trandingview |
Health Technology
| | O: -0.11% H: 0.15% C: -1.38%

weight loss chinese obesity phase 1 results metabolic phase 1b lancet phase 2b
Gainers vs Losers
67% 33%

Top 10 Gainers
AGBA | News | $1.26 215.0% 68.25% 130M twitter stocktwits trandingview |
Finance

EGOX | $0.0515 43.06% 30.1% 330M twitter stocktwits trandingview |

OLB 4 | $0.33 -14.95% 25.53% 840K twitter stocktwits trandingview |
Technology Services

NVFY | $2.77 31.28% 23.83% 33M twitter stocktwits trandingview |
Consumer Durables

ZCMD | $1.87 28.97% 22.46% 31M twitter stocktwits trandingview |
Commercial Services

RCON | $0.1112 13.01% 21.28% 1.7M twitter stocktwits trandingview |
Distribution Services

INSG | $3.03 25.21% 20.13% 330K twitter stocktwits trandingview |
Electronic Technology

GCTK | $0.8191 22.25% 18.2% 190K twitter stocktwits trandingview |
Manufacturing

WLGS | $0.59 18.0% 17.9% 2.3M twitter stocktwits trandingview |

ASNS | $0.828 21.75% 17.86% 18K twitter stocktwits trandingview |


Your saved searches
Save your searches and get alerts when important news are released.